Guided Therapeutics, Inc.
GTHP
$0.25
$0.0525.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.23% | -22.27% | -16.93% | 19.19% | 30.73% |
| Total Depreciation and Amortization | 12.63% | 10.75% | 11.11% | 10.23% | 11.76% |
| Total Amortization of Deferred Charges | 121.82% | 116.19% | 69.57% | 11.54% | -15.38% |
| Total Other Non-Cash Items | 775.56% | 695.59% | 788.57% | -94.00% | -94.49% |
| Change in Net Operating Assets | -1.40% | -12.47% | -22.19% | 129.62% | 1,055.24% |
| Cash from Operations | 4.56% | 1.25% | -16.21% | -0.22% | 35.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 27.43% | 112.66% | 373.50% | -- | -- |
| Total Debt Repaid | -13.21% | -76.36% | -32.81% | -102.10% | -15.78% |
| Issuance of Common Stock | -32.10% | 46.95% | 246.47% | 246.47% | 91.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.45% | -113.79% | -235.29% | -- | -- |
| Cash from Financing | -18.67% | 71.33% | 2,937.50% | 2,366.67% | 3,716.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.10% | 80.07% | 91.69% | 76.29% | 88.21% |